SCHEMBL6847255

SCHEMBL6847255

CCCC(CO)n1c(N)nc2nc[nH]c2c1=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.38
PDE4B Q07343 5/20 0.38
PDE4C Q08493 5/20 0.38
PDE4D Q08499 5/20 0.38
CDK1 P06493 6/20 0.38
CCNB1 P14635 6/20 0.38
CCNA2 P20248 5/20 0.38
CDK2 P24941 5/20 0.38
CCNA1 P78396 5/20 0.38
XDH P47989 3/20 0.38
PIN1 Q13526 1/20 0.37
ADORA2A P29274 3/20 0.37
ADORA2B P29275 3/20 0.37
MGMT P16455 2/20 0.37
PNP P00491 1/20 0.37
PDPK1 O15530 1/20 0.36
GDA Q9Y2T3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6266585 0.84 CDK1 (0.40) PDE4APDE4BPDE4CPDE4DCDK1
SCHEMBL6847248 0.81 PDE4A (0.33) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL2385930 0.80 ADORA2B (0.50) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL15743135 0.78 CDK1 (0.42) PDE4APDE4BPDE4CPDE4DCDK1
SCHEMBL6751932 0.78 PNP (0.43) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL5503610 0.77 CDK1 (0.42) PDE4APDE4BPDE4CPDE4DCDK1
SCHEMBL8214982 0.76 XDH (0.45) PDE4APDE4BPDE4CPDE4DCDK1
SCHEMBL441798 0.75 DPP4 (0.44) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL16098082 0.73 PNP (0.37) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL28237494 0.73 DPP4 (0.42) CDK1CCNB1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104093830-A Clonal strains of attenuated vaccinia virus and methods of use thereof GENELUX CORP 2014-10-08 CN disclosed
EP-1372664-A1 USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES Hollis-Eden Pharmaceuticals Inc. (US) 2004-01-02 EP disclosed
WO-2002069977-A1 USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2002-09-12 WO disclosed
WO-2000006573-A1 ANTIVIRAL ALKYL SUBSTITUTED PURINE DERIVATIVES AND THEIR PREPARATION Kemijski inštitut (SI) 2000-02-10 WO disclosed